{"name":"Tor Biering-Sørensen","slug":"tor-biering-s-rensen","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"High-Dose Quadrivalent Influenza Vaccine","genericName":"High-Dose Quadrivalent Influenza Vaccine","slug":"high-dose-quadrivalent-influenza-vaccine","indication":"Influenza prevention in adults aged 65 years and older","status":"marketed"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Standard-Dose Influenza Vaccine","genericName":"Standard-Dose Influenza Vaccine","slug":"standard-dose-influenza-vaccine","indication":"Prevention of seasonal influenza in adults and children ≥6 months of age","status":"marketed"}]}],"pipeline":[{"name":"High-Dose Quadrivalent Influenza Vaccine","genericName":"High-Dose Quadrivalent Influenza Vaccine","slug":"high-dose-quadrivalent-influenza-vaccine","phase":"marketed","mechanism":"A high-dose inactivated influenza vaccine that stimulates a stronger immune response by delivering four times the standard antigen dose to enhance antibody production and cellular immunity against four influenza virus strains.","indications":["Influenza prevention in adults aged 65 years and older","Influenza prevention in immunocompromised adults"],"catalyst":""},{"name":"Standard-Dose Influenza Vaccine","genericName":"Standard-Dose Influenza Vaccine","slug":"standard-dose-influenza-vaccine","phase":"marketed","mechanism":"Standard-dose influenza vaccine stimulates the immune system to produce antibodies and cellular immunity against circulating influenza virus strains.","indications":["Prevention of seasonal influenza in adults and children ≥6 months of age"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE40NFByMVdBc0dTQ0pqS0MyUldwVzlFbmRib3l5eEprU2U0Si04UVg0djc5Mi11ZEc2cmZWOHlRelRMWVdYYUV6NkhSZWtielhOZXNVSmIxWlA5YVdTNnE0YVNkX3RRMzRFZlE?oc=5","date":"2025-11-30","type":"pipeline","source":"Wiley Online Library","summary":"Journal of Internal Medicine - Wiley Online Library","headline":"Journal of Internal Medicine","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxPTVp1QkJrcGk2WjZSUWdBRkVoUWlSYU8zazl4WjlDMmNWbU9LOFhLeF91X0xNQTBqMVM3WmZIOVd5bmlhYXEyeXAwVXZpU3I1LWFLaUpCazlMeDBYTlNteFVpR1dYdTR6Yko5TGVyczlpbnY5V2tRVXBtVkhJa0FNVTVGRWFia2laQTV1R3Q2OUQ2dnQ5R2M4SlRpSjFLQ1VUVVY5YWVZNldQeGF6TEFFS2pWaGtlcnhOX3ZYVENHWG5GLUc3VzYtZFFWdkQ5OG43cWc?oc=5","date":"2025-10-21","type":"pipeline","source":"BioPharma APAC","summary":"Sanofi’s Efluelda (Fluzone High-Dose) Cuts Influenza Hospitalisations by 31.9% in Adults Aged 65+ - BioPharma APAC","headline":"Sanofi’s Efluelda (Fluzone High-Dose) Cuts Influenza Hospitalisations by 31.9% in Adults Aged 65+","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNazZ3cG5aZldoY19yUTd2OTN3MEItbk9RdHlnZ3hkR1A0TE10Q1lqaFRhV2YyOVJYalV4UXZTbGZOdkF2VnNsVEFRb202bTlCZmRERTlDM2lHd0d4SHdJVV9aS3JaaXhrME95RTI2VUdfUlZPOThDcHRDb044bjZHYVFyZUt5T1N2RDB4Y3JpZW5YTkVLS0syNUlWYWIyX05aRGhfUm9KVmc?oc=5","date":"2025-10-21","type":"pipeline","source":"PMLiVE","summary":"Sanofi reports improved patient outcomes from high-dose influenza vaccine - PMLiVE","headline":"Sanofi reports improved patient outcomes from high-dose influenza vaccine","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYEFVX3lxTE16aS1VYjk0NVJnQzZtQWVRX25zSnlIbF9TU0I1UmFDQldUVHlIYW95SFo3ZDJwbmo1WXRkaFlxMEFQNmRRY0xFQzB2bm80a3IwMEFMdHRLVm0xSnhyUTNJYQ?oc=5","date":"2025-08-30","type":"trial","source":"JACC Journals","summary":"Effect of RSV Vaccine on Heart Failure Hospitalizations: A Prespecified Analysis of the DAN-RSV Trial - JACC Journals","headline":"Effect of RSV Vaccine on Heart Failure Hospitalizations: A Prespecified Analysis of the DAN-RSV Trial","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMib0FVX3lxTE83N2dTakxGWVBxdm1uVUFuUnQ3SmdnUi16Q1htaUZYQmlGX2lLcS1MNGdscGRrd0o0d3FiYWFMYURzZ0xOZnZocFNIc0szMDJjUDR6c1dzTnFpaHRUYThLWEhBNFdFRExBVzAzdnZGUQ?oc=5","date":"2025-03-10","type":"pipeline","source":"MedPage Today","summary":"Can Flu Shot Nudges Lead to Fewer COVID Vaccinations? - MedPage Today","headline":"Can Flu Shot Nudges Lead to Fewer COVID Vaccinations?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxQN0VsNUluNHU2R3FtTUpvUmJ6SEVrVGY5LTV1ZDZUYWw4LWJySW9HM0MwSEdQZVVhazRjU29vU1l1TDgtbWphZHFsa0VsMGNaREFtN19NeG5TOWRnaUg2b1hIZnh1ZTNDSUlKRTRzSHJ0NVVBYXZsVnlMam5JalBPWVhEM0laRzdfX1lITVlDWERmbkt1UHQ2bERYRVVYTVRTZXFlMUhGWHU1U3dnWEc5VGxVVTZCalRiTHpQOF8ySQ?oc=5","date":"2023-03-05","type":"pipeline","source":"dicardiology.com","summary":"Linking Flu Vaccination to Potential Cardiovascular Benefits Gets More People to Roll Up Their Sleeves - dicardiology.com","headline":"Linking Flu Vaccination to Potential Cardiovascular Benefits Gets More People to Roll Up Their Sleeves","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMia0FVX3lxTE5nSnlGOXd6ckpKcDRoaWl5aS05Zy0ya3ZpTC1CQjBOWTNVNXFkOHFQeWcyQzlLbVZKY1JFSFhOeUhvdlNscElUdEhXaWhnUi1EUG1Pd0dhRF9CdmZEZEdmc05qSjVCYU5fU0dV?oc=5","date":"2021-09-17","type":"pipeline","source":"Wiley Online Library","summary":"Heart failure in COVID‐19: the multicentre, multinational PCHF‐COVICAV registry - Wiley Online Library","headline":"Heart failure in COVID‐19: the multicentre, multinational PCHF‐COVICAV registry","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"marketed":2},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}